Pfizer is a large multinational company and Lipitor is one of the major medicines though which it has received billions of dollars in profits, but when its patent period was about to finish, it purposely tried to stop the sale of generic medicines through illegal means. Pfizer was in a middle of a lawsuit filed in Australia when its drug Lipitor went off patent and generics sale started to increase. It somehow managed to face competition by offering deals to pharmacies to limit their purchases of the generic drug. Generic medicines provide financial relief to consumers, but have been spoiling Pfizer’s revenues along with continuous expiration of its patented drugs (McGrath, 2014). It is seen here that Pfizer also wanted to avoid the introduction of the generic version of their drugs, so that they could enjoy the prestigious sales volumes and profits through the sale of its blockbuster brand. The action of Pfizer is similar to ITP which also played its part in restricting the sale of the generic version of its medicines. It used every possible method including political influence to avoid the introduction of the generic version which ultimately would have made patients happier because of low cost medication. Thus the pharmaceutical industry is clouded with such incidences where they indulge in illegal and immoral means to maximize the sales of their medicines and restrict the sale of generic versions. ITP has acted similarly to shift its base and influence government officials to somehow manage to keep the low cost medicines away from the market. Thus ITP has not followed a legitimate process internally which it proudly vouched for externally of banning such drugs which are used for executing people.